FMFC, the Nasdaq-listed Kandal M Venture Limited, is trading with a striking disconnect between its borrow cost and actual short positioning — the kind of setup that makes a $6 million micro-cap worth a closer look.
The most unusual feature of this week's data is how expensive it is to borrow FMFC shares relative to how few people are actually doing it. Cost to borrow is running at 60.3% annualised — genuinely elevated for any stock, and still above the mid-40s range seen in late March after a peak above 100% in mid-March. Yet the lending pool is essentially empty. Availability has ballooned to over 2,700% of outstanding short interest, meaning there are more than twenty-seven shares available to borrow for every one currently lent out. That loose supply means bears face no squeeze pressure and no scarcity premium — the 60% cost appears to reflect structural illiquidity in the stock rather than competitive demand for borrows.
Short positioning itself is modest but has been creeping higher. SI reached 2.47% of the free float on May 7, up roughly 10% from a month ago and touching its highest level since late April's brief dip. The move is gradual rather than aggressive — short shares climbed from around 175,000 in late March to just over 205,000 now. With a days-to-cover of just 1.0, there is no meaningful squeeze mechanic in play, and the ORTEX short score of 44.7 sits in the lower half of the universe, consistent with a stock that shorts are monitoring but not piling into.
The price action adds context. FMFC closed at $0.41 on May 8, up 10.4% on the week and 2.5% on the day — a material move for a stock at this price point. The company put out positive forward guidance on April 17, flagging expectations for FY26 revenue and net income to beat the prior year's ~$17.2 million in revenue and ~$210,000 net income. That announcement followed a brutal March earnings reaction: the stock fell nearly 28% in a single session on March 20 and shed a further 38% over the subsequent five days. The week's rally looks like partial recovery off those lows rather than a fresh breakout.
Ownership concentration is extreme. A single insider, Duncan Miao, holds 52.2% of shares outstanding, last reported as of February 2026 with no change. DMD Ventures Limited added 416,842 shares in the same period. The remaining institutional holders — Citadel, Two Sigma, Jane Street — each hold fractions below 0.25% and appear to have been new positions as of year-end 2025. With more than half the float effectively locked up, the tradeable float is tiny, which helps explain why an 60% cost to borrow coexists with near-zero utilisation: there simply are not many shares in active circulation, and most of what exists is not in borrow programmes at all.
The next earnings event is scheduled for July 30. Given the stock's history — three of the last four prints produced same-day moves of -4% to -28%, and five-day moves swinging from +47% to -38% — that date will carry outsized weight for a name where daily volumes can be thin and sentiment can shift sharply. What to watch between now and then is whether the May price recovery holds above the $0.40 level, and whether the company provides any interim operational update that either validates or challenges its April guidance upgrade.
See the live data behind this article on ORTEX.
Open FMFC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
